Dementia Clinical Trials

 

Alzheimer’s clinical trials

The clinical trials unit at Caulfield Hospital specialises in new treatments for Alzheimer’s disease.

Our Alzheimer's trials

Our team consists of doctors, nurses, neuropsychologists, and clinical trials coordinators with expertise in clinical trials for people with cognitive problems, including various types of dementia and neurodegenerative disorders.

Our main focus is on new medications for Alzheimer’s disease, both disease modifying drugs and symptomatic therapies. There are many treatments under development and we are usually recruiting interested patients into new studies.

Accessing Alzheimer's clinical trials

In order to be eligible to enter a clinical trial, participants need to have a formal diagnosis of Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s. The diagnosis is usually made by a specialist, often a geriatrician, psychogeriatrician, neurologist or psychiatrist. Our service does not provide diagnostic cognitive assessments.

If you would like to know more about current clinical trials please contact us:

Members of the MAPrc Caulfield Dementia Clinical Trials Team